Novavax COVID vaccine effective vs. B.1.351 variant, inks deal with Gavi
Novavax announced results of a phase IIB trial of its COVID-19 candidate vaccine (NVX-CoV2373) published May 5 in the New England Journal of Medicine that suggest the vaccine is effective against the B.1.351 variant prevalent in South Africa. Read More
Bio-Techne posts revenue gains in Q3
Bio-Techne reported strong growth in revenues for its third quarter, thanks largely to sales in its protein analysis business. Read More
Sanofi, Stanford partner to study immunology
Sanofi has entered into a three-year research collaboration with the Stanford University School of Medicine to advance the understanding of immunology and inflammation. Read More
Dyno Therapeutics nabs $100M for AI gene therapy platform
Dyno Therapeutics has closed $100 million in financing to expand its CapsidMap platform, which uses artificial intelligence (AI) technology to design novel adeno-associated virus gene therapy vectors, thereby enhancing the therapeutic effect of gene therapies. Read More
Errant Gene Therapeutics changes name to San Rocco Therapeutics
Errant Gene Therapeutics, founded in 1993 after founder Pat Girondi's son was diagnosed with thalassemia, will become San Rocco Therapeutics, after San Rocco, the patron saint of hopeless disease. Read More
Cellares raises $82M to make scalable 'factory-in-a-box'
Life sciences technology company Cellares has raised $82 million in financing to accelerate the development of the scalable factory-in-a-box Cell Shuttle. Read More
Athenex to acquire Kuur to develop cell therapies
Athenex plans to acquire Kurr Therapeutics to expand its cell therapy development. Read More
PerkinElmer posts major gains in Q1
PerkinElmer reported sharp increases in revenues and net income for the first quarter of 2021. Read More
Waters reports 30% sales increase in Q1
Lab equipment supplier Waters reported significant sales growth during the first quarter of 2021. Read More
Crown Bioscience acquires in vitro services provider OcellO
Crown Bioscience, a JSR Life Sciences company, has acquired OcellO, a privately owned contract research organization in the Netherlands. Read More
Member Rewards
Earn points for contributing to market research. Redeem your points for merchandise, travel, or even to help your favorite charity.
Research Topics
Interact with an engaged, global community of your peers who come together to discuss their work and opportunities.
Connect
